Eledon Pharmaceuticals Inc Share Price Today: Live Updates & Key Insights

Eledon Pharmaceuticals Inc share price today is $2.9964, up 1.05%. The stock opened at $2.915 against the previous close of $2.85, with an intraday high of $3.1025 and low of $2.86.

Eledon Pharmaceuticals Inc Share Price Chart

Eledon Pharmaceuticals Inc

us-stock
To Invest in {{usstockname}}
us-stock

Eledon Pharmaceuticals Inc Share Price Performance

$2.9964 0.0105(1.05%) ELDN at 23 Mar 2026 12:51 PM Biotechnology
Lowest Today 2.86
Highest Today 3.1025
Today’s Open 2.915
Prev. Close 2.85
52 Week High 4.60
52 Week Low 1.35
Day’s Range: Low 2.86 High 3.1025
52-Week Range: Low 1.35 High 4.60
1 day return -
1 Week return +4.18
1 month return +25.71
3 month return +74.39
6 month return +10.42
1 year return -20.66
3 year return +26.54
5 year return -79.57
10 year return -

Eledon Pharmaceuticals Inc Institutional Holdings

Bvf Inc 7.90

Vanguard Group Inc 5.07

BlackRock Inc 4.35

Defilade Capital Management, L.P. 4.13

Ensign Peak Advisors Inc 3.10

Zimmer Partners LP 2.99

Vanguard Total Stock Mkt Idx Inv 2.96

Sphera Funds Management Ltd. 2.68

Blue Owl Capital Holdings LP 2.42

ADAR1 Capital Management LLC 2.29

Geode Capital Management, LLC 1.79

iShares Russell 2000 ETF 1.76

Catalio Capital Management, LP 1.58

Awm Investment Company Inc 1.38

Kingdon Capital Management LLC 1.31

Stonepine Capital Management Llc 1.12

Sanofi 1.02

Vanguard Institutional Extnd Mkt Idx Tr 1.02

Kovitz Investment Group Partners, LLC 0.92

State Street Corp 0.82

CM Management, LLC 0.82

22NW, LP 0.80

Fidelity Small Cap Index 0.70

Caligan Partners LP 0.70

iShares Russell 2000 Value ETF 0.58

Fidelity Extended Market Index 0.47

Vanguard Russell 2000 ETF 0.34

Blackrock Extended Mkt Fund CF 0.30

State St Russell Sm Cap® Indx SL Cl I 0.26

Extended Equity Market Fund K 0.26

iShares Micro-Cap ETF 0.18

Schwab Small Cap Index 0.18

Fidelity Total Market Index 0.15

NT R2000 Index Fund - NL 0.15

NT Ext Equity Mkt Idx Fd - L 0.13

iShares Russell 2000 Small-Cap Idx Instl 0.13

NT R2000 Index Fund - DC - NL - 3 0.12

Fidelity Series Total Market Index 0.11

Russell 2500™ Index Fund F 0.11

Wellington CIF II Small Cap 2000 0.10

Eledon Pharmaceuticals Inc Market Status

Strong Buy: 5

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

Eledon Pharmaceuticals Inc Fundamentals

Market Cap 229.34 M

PB Ratio 6.4745

PE Ratio 0.0

Enterprise Value 136.26 M

Total Assets 169.01 M

Volume 4028602

Eledon Pharmaceuticals Inc Company Financials

Annual Revenue FY24:null 0.0M, FY23:0 0.0M, FY22:0 0.0M, FY21:120000 0.1M, FY20:120000 0.1M

Annual Profit FY24:-374000 -0.4M, FY23:null 0.0M, FY22:null 0.0M, FY21:120000 0.1M, FY20:120000 0.1M

Annual Net worth FY24:-40326000 -40.3M, FY23:-89084000 -89.1M, FY22:-87504000 -87.5M, FY21:-34506000 -34.5M, FY20:-22811000 -22.8M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:560000 0.6M

Quarterly Profit Q3/2025:null 0.0M, Q2/2025:null 0.0M, Q1/2025:null 0.0M, Q3/2024:null 0.0M, Q2/2024:-97000 -0.1M

Quarterly Net worth Q3/2025:-17459000 -17.5M, Q2/2025:-11216000 -11.2M, Q1/2025:-6495000 -6.5M, Q3/2024:76971000 77.0M, Q2/2024:-44907000 -44.9M

About Eledon Pharmaceuticals Inc & investment objective

Company Information Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It uses its immunology expertise in targeting the CD40 Ligand (CD40L) pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis (ALS). The company's lead compound in development is tegoprubart, an IgG1 and anti-CD40L antibody with high affinity for CD40 Ligand, a biological target with therapeutic potential. It is also developing its products for the prevention of allograft rejection in kidney transplantation and xenotransplantation. The company has a collaboration agreement with eGenesis, Inc. The company also has a strategic collaboration with NewcelX Ltd. for the development of the NCEL-101 therapy for Type 1 Diabetes. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2021. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California.

Organisation Biotechnology

Employees 33

Industry Biotechnology

CEO Dr. David-Alexandre C. Gros M.D., Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Eledon Pharmaceuticals Inc FAQs

What is the share price of Eledon Pharmaceuticals Inc today?

The current share price of Eledon Pharmaceuticals Inc is $2.9964.

Can I buy Eledon Pharmaceuticals Inc shares in India?

Yes, Indian investors can buy Eledon Pharmaceuticals Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Eledon Pharmaceuticals Inc shares in India?

You can easily invest in Eledon Pharmaceuticals Inc shares from India by:

Can I buy fractional shares of Eledon Pharmaceuticals Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Eledon Pharmaceuticals Inc?

Eledon Pharmaceuticals Inc has a market cap of $229.34 M.

In which sector does Eledon Pharmaceuticals Inc belong?

Eledon Pharmaceuticals Inc operates in the Biotechnology sector.

What documents are required to invest in Eledon Pharmaceuticals Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Eledon Pharmaceuticals Inc?

The PE ratio of Eledon Pharmaceuticals Inc is N/A and the PB ratio is 6.47.